• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue . Clinical characteristics and prognostic factors of adult patients with acute respiratory failure due to infl

tetano

Editor, Senior Moderator
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue


. 2020 Nov;32(11):1304-1309.
doi: 10.3760/cma.j.cn121430-20200827-00598.
[Clinical characteristics and prognostic factors of adult patients with acute respiratory failure due to influenza infection]


[Article in Chinese]

Jiali Duan[SUP] 1 [/SUP], Yuejie Yang[SUP] 2 [/SUP], Shuya Hou[SUP] 2 [/SUP], Xia Xing[SUP] 1 [/SUP], Mengfei Sun[SUP] 1 [/SUP], Yang Liu[SUP] 1 [/SUP], Lihua Xing[SUP] 1 [/SUP]



Affiliations

Abstract

Objective: To investigate the clinical characteristics and prognostic predictors of adult patients with acute respiratory failure due to influenza infection.
Methods: A retrospective analysis was performed on adult patients with acute respiratory failure due to confirmed influenza infection admitted to intensive care units (ICU) of the First Affiliated Hospital of Zhengzhou University and the Sixth People's Hospital of Zhengzhou between January 2018 and January 2020. The subjects were divided into survival and death groups according to whether the patients died before discharge. Demographic and clinical data including underlying conditions, laboratory variables, therapy and prognostic factors of hospital mortality between the two groups were analyzed. The risk factors of mortality were evaluated by univariate and multivariate Logistic regression analysis. Then, the correlation between lymphocyte (LYM) count and LYM subsets were analyzed. The survival rates of different acute physiologic and chronic health evaluation II (APACHE II) and LYM level subgroups were compared.
Results: A total of 104 patients were enrolled. Among them, 67 cases (64.4%) had underlying conditions, 91.3% of the patients (95 cases) were infected by influenza A virus, and the hospital mortality rate was 39.4% (41 cases). Compared with survival group, the patients of death group had higher respiratory rate (times/min: 26.0?5.6 vs. 23.7?5.0), APACHE II score (18.20?4.88 vs. 12.35?4.58), procalcitonin [PCT (μg/L): 0.82 (0.23, 4.63) vs. 0.39 (0.11, 0.92)], higher percentage of cardiovascular disease [24.4% (10/41) vs. 7.9% (5/63)] and invasive mechanical ventilation [63.4% (26/41) vs. 17.5% (11/63), all P < 0.01], but had lower oxygenation index [PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] (mmHg, 1 mmHg = 0.133 kPa): 131.8?34.5 vs. 181.7?31.6] at ICU admission, LYM (?10[SUP]9[/SUP]/L: 0.53?0.40 vs. 0.92?0.44), hemoglobin [Hb (g/L): 105.66?28.17 vs. 118.29?28.29], platelet count [PLT (?10[SUP]9[/SUP]/L): 135.12?85.40 vs. 199.81?110.11], T lymphocyte count [cells/μL: 181 (131, 275) vs. 319 (238, 528)], CD4[SUP]+[/SUP] count [cells/μL: 110 (71, 161) vs. 190 (120, 311)] and CD8[SUP]+[/SUP] count [cells/μL: 71 (33, 100) vs. 121 (81, 188), all P < 0.01]. Patients of death group also had a shorter length of hospital stay [days: 7.0 (4.0, 11.0) vs. 12.0 (8.0, 20.0), P < 0.01]. Univariate analysis showed that APACHE II score [odds ratio (OR) = 1.207, 95% confidence interval (95%CI) was 1.094-1.332, P < 0.001], LYM (OR = 0.070, 95%CI was 0.018-0.271, P < 0.001), Hb (OR = 0.984, 95%CI was 0.970-0.999, P = 0.031), PLT (OR = 0.992, 95%CI was 0.987-0.997, P = 0.003), T lymphocyte count (OR = 0.996, 95%CI was 0.993-0.998, P = 0.001) and PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] (OR = 0.955, 95%CI was 0.938-0.972, P < 0.001) were the risk factors for the prognosis of influenza patients with acute respiratory failure. Further multivariate Logistic analysis also showed that APACHE II score (OR = 1.195, 95%CI was 1.041-1.372, P = 0.011), LYM (OR = 0.063, 95%CI was 0.011-0.369, P = 0.002) and PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] (OR = 0.953, 95%CI was 0.933-0.973, P < 0.001) were the predictors of mortality. Moreover, patients with peripheral blood LYM < 0.65?10[SUP]9[/SUP]/L or APACHE II score > 14 had a higher risk of poor outcome. There were significantly positive correlation between LYM and LYM subsets (T lymphocyte, CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] lymphocyte, r value was 0.593, 0.563, and 0.500, respectively, all P < 0.001).
Conclusions: Influenza patients with acute respiratory failure were critically ill and had a high mortality rate. APACHE II score, PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] and LYM at ICU admission were independent risk factors affecting the prognosis of patients.
 
Back
Top Bottom